Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S. -- and one that’s already available in Europe and multiple other countries.
has bought 3.2 million Novavax doses so far, and Erck said vaccinations should begin later this month.
Her husband's positive experience with a more tried-and-true technology, "that convinced me," Bentley said, adding that she planned to tell some unvaccinated friends about the option, too. Like the other vaccines used in the U.S., the Novavax shots have proved highly effective at preventing COVID-19's most severe outcomes. Typical vaccine reactions were mild, including arm pain and fatigue. But FDA did warn about the possibility of a rare risk, heart inflammation, that also has been seen with the Pfizer and Moderna vaccines.struck.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US regulators OK new COVID-19 shot option from NovavaxThe U.S. is getting another COVID-19 vaccine choice
Read more »
US regulators OK new COVID-19 shot option from NovavaxNovavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S.
Read more »
U.S. health officials approve new COVID-19 shot from NovavaxThe U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults. Novavax makes a more...
Read more »
US regulators OK new COVID-19 shot option from NovavaxNovavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S.
Read more »
FDA authorizes Novavax COVID-19 vaccineThe FDA on Wednesday issued an emergency use authorization for Novavax's COVID-19 vaccine for adults 18 and older.
Read more »
FDA Clears New COVID-19 Vaccine Option From Novavax for AdultsNearly a quarter of American adults still haven't gotten their primary vaccinations even this late in the COVID pandemic, and experts expect at least some of them to roll up their sleeves for a more conventional option — a protein-based vaccine.
Read more »